Cullinan Therapeutics, Inc. Common Stock vs. Halozyme Therapeutics, Inc.
CGEM
Cullinan Therapeutics, Inc. Common Stock
$16.87 -22.15%
VS HALOHalozyme Therapeutics, Inc.
$112.91 -1.93%
Halozyme Therapeutics, Inc. (HALO) comes out ahead, leading on 4 of 6 compared factors.
Size & Scale
| CGEM | HALO | |
|---|---|---|
| Market Cap | $1.39 billion | $13.07 billion |
| Revenue (TTM) | — | $1.66 billion |
| Net Income (TTM) | $-204,688,000 | $413.60 million |
HALO leads on 3 of 3 size & scale factors.
Valuation
| CGEM | HALO | |
|---|---|---|
| P/E Ratio | — | 33.01 |
| Price / Book | 4.33 | 91.03 |
| Price / Sales | — | 7.85 |
CGEM leads on 1 of 1 valuation factors.
Profitability
| CGEM | HALO | |
|---|---|---|
| Net Margin | — | 24.86% |
| Return on Equity | -63.62% | 288.13% |
HALO leads on 1 of 1 profitability factors.
Risk & Sentiment
| CGEM | HALO | |
|---|---|---|
| Short Interest | 0.01% | 9.79% |
CGEM leads on 1 of 1 risk & sentiment factors.
Dig deeper: CGEM overview, CGEM financials, HALO overview, HALO financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.